Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Dr Lal Pathlabs has informed about the details of Analyst/Institutional Investor meetings are as per attached file.
The above information is a part of company’s filings submitted to BSE.